<p><img src="https://imageproxy.pbkrs.com/https://invezz.com/wp-content/uploads/2025/09/solana-wall-street.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://invezz.com/wp-content/uploads/2025/09/solana-wall-street.png"/></p>
<p>罗素 2000 指数和 IWM ETF 今年上涨了 13%，全球股票持续上涨。过去五年中，该指数上涨超过 25%，但表现不及道琼斯和纳斯达克 100 等其他蓝筹指数。本文探讨了今年罗素指数中的一些主要涨幅股票。</p>
<p><img src="https://imageproxy.pbkrs.com/https://invezz.com/wp-content/uploads/2025/12/Russell-2000-Index-1024x579.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://invezz.com/wp-content/uploads/2025/12/Russell-2000-Index-1024x579.png"/></p>
<p><em>罗素 2000 指数图表 | 来源：TradingView</em></p>
<h2>肿瘤研究所是罗素 2000 指数中的最大赢家</h2>
<p>肿瘤研究所是一家为近 200 万癌症患者提供服务的公司，今年在罗素 2000 指数中表现最佳，涨幅超过 1,090%。其股价最高达到 4.85 美元，比年初最低点上涨超过 2,100%。</p>
<p>该公司受益于收入增长。预计今年年收入将从去年的 3.93 亿美元跃升至 5 亿美元。大部分收入来自专业药房业务，其次是服务费用和人头费。</p>
<p>随着美国癌症病例的持续增长，肿瘤研究所可能会继续表现良好。</p>
<p>罗素 2000 指数中的其他主要赢家是生物技术行业的公司，如 Palvella Therapeutics、Cidara Therapeutics、Terns Pharmaceuticals、Nutex Health 和 Zenas BioPharma。这些股票今年均上涨超过 370%，因为它们在研究方面取得了进展。</p>
<h2>Planet Labs (PL)</h2>
<p>Planet Labs 是罗素 2000 指数和 IWM ETF 中表现第二好的公司，且不属于生物技术行业。其股价今年最高达到 20.90 美元，比历史最低点上涨了 1,098%。</p>
<p>该公司处于卫星图像行业，在管理层宣布强劲的收益和指引后股价大幅上涨。其最新数据显示，第四季度的收入将在 7600 万到 8000 万美元之间，高于之前的指引 7350 万美元。</p>
<p>该公司还预计年收入将在 2.97 亿到 3.01 亿美元之间，高于分析师的预期。这一增长发生在公司转向政府合同的过程中，而其商业业务仍面临压力。</p>
<h2>EcoStar Corporation 股票在 SpaceX IPO 前大幅上涨</h2>
<p>另一家显著的赢家是 EchoStar，其股票今年上涨了 356%。这一增长发生在公司与 SpaceX 继续合作的背景下。最近，该公司与 SpaceX 达成了一项价值 26 亿美元的协议。根据该协议，该公司将获得来自 SpaceX 的 26 亿美元的频谱费用。</p>
<p>该公司与 AT&amp;T 和 SpaceX 等公司达成的频谱交易总价值超过 400 亿美元。此外，分析师预计在 SpaceX 上市后，其交易将加速。</p>
<h2>ThredUp (UP)</h2>
<p>ThredUp 是一家提供二手衣物平台的公司，是罗素 2000 指数中的另一家主要赢家，今年上涨了 332%。随着公司在持续的通货膨胀环境中看到更多需求，其增长加速。</p>
<p>由于投资者将其视为一个良好的转型故事，并且其已建立起良好的轻资产转售基础设施，其股价也大幅上涨。然而，其股价的飙升也吸引了空头，空头头寸上升至 15%，这表明一些投资者预计其将很快回落。</p>
<p>罗素 2000 指数中的其他主要赢家包括 Hecla Mining、Bloom Energy、ViaSat、Better Home &amp; Finance、US Gold、Oklo 和 SSR Mining 等公司。</p>
<p>本文《2025 年罗素 2000 指数和 IWM ETF 中的主要赢家》首次出现在 Invezz 上。</p>

回声星通信

PVLA

CDTX

TDUP

<p>罗素 2000 指数和 IWM ETF 今年上涨了 13%，五年内增长了 25%，但仍落后于主要指数。肿瘤研究所的涨幅最大，增长超过 1090%，主要得益于收入增长。其他涨幅较大的公司包括 Planet Labs（上涨 1098%）、EchoStar（上涨 356%）和 ThredUp（上涨 332%）。生物技术行业也出现了显著增长，像 Palvella Therapeutics 和 Cidara Therapeutics 等公司上涨超过 370%</p>

<p><img src="https://imageproxy.pbkrs.com/https://invezz.com/wp-content/uploads/2025/09/solana-wall-street.png" alt="" original-src="https://invezz.com/wp-content/uploads/2025/09/solana-wall-street.png"/></p>
<p>The Russell 2000 Index and the IWM ETFs jumped by 13% this year as global stocks continued their uptrend. It has now risen by over 25% in the last five years, underperforming other blue-chip indices like the Dow Jones and the Nasdaq 100. This article explores some of the top gainers in the Russell Index this year.</p>
<div class="lb-trans"><p>罗素 2000 指数和 IWM ETF 今年上涨了 13%，全球股票持续上涨。过去五年中，该指数上涨超过 25%，但表现不及道琼斯和纳斯达克 100 等其他蓝筹指数。本文探讨了今年罗素指数中的一些主要涨幅股票。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://invezz.com/wp-content/uploads/2025/12/Russell-2000-Index-1024x579.png" alt="" original-src="https://invezz.com/wp-content/uploads/2025/12/Russell-2000-Index-1024x579.png"/></p>
<p><em>Russell 2000 Index chart | Source: TradingView</em></p>
<div class="lb-trans"><p><em>罗素 2000 指数图表 | 来源：TradingView</em></p>
</div><h2>The Oncology Institute was the top gainer in the Russell 2000 Index</h2>
<div class="lb-trans"><h2>肿瘤研究所是罗素 2000 指数中的最大赢家</h2>
</div><p>The Oncology Institute, a company serving nearly 2 million cancer patients, was the best-performing company in the Russell 2000 Index this year as it jumped by over 1,090%. It rose to a high of $4.85, up by over 2,100% from the year-to-date low.</p>
<div class="lb-trans"><p>肿瘤研究所是一家为近 200 万癌症患者提供服务的公司，今年在罗素 2000 指数中表现最佳，涨幅超过 1,090%。其股价最高达到 4.85 美元，比年初最低点上涨超过 2,100%。</p>
</div><p>The company benefited from the rising revenue growth. It estimates that its annual revenue will jump to $500 million this year from $393 million last year. Most of this revenue came from the specialty pharmacy business, followed by fee for services and capitation.</p>
<div class="lb-trans"><p>该公司受益于收入增长。预计今年年收入将从去年的 3.93 亿美元跃升至 5 亿美元。大部分收入来自专业药房业务，其次是服务费用和人头费。</p>
</div><p>The Oncology Institute will likely continue doing well as cancer cases in the United States continue growing over time.</p>
<div class="lb-trans"><p>随着美国癌症病例的持续增长，肿瘤研究所可能会继续表现良好。</p>
</div><p>The other top gainers in the Russell 2000 Index were companies in the biotechnology industry like Palvella Therapeutics, Cidara Therapeutics, Terns Pharmaceuticals, Nutex Health, and Zenas BioPharma. All these stocks jumped by over 370% this year as they made progress in their research.</p>
<div class="lb-trans"><p>罗素 2000 指数中的其他主要赢家是生物技术行业的公司，如 Palvella Therapeutics、Cidara Therapeutics、Terns Pharmaceuticals、Nutex Health 和 Zenas BioPharma。这些股票今年均上涨超过 370%，因为它们在研究方面取得了进展。</p>
</div><h2>Planet Labs (PL)</h2>
<div class="lb-trans"><h2>Planet Labs (PL)</h2>
</div><p>Planet Labs was the second-best-performing company in the Russell 2000 Index and the IWM ETF which is not in the biotechnology industry. Its stock jumped to a high of $20.90 this year, up by 1,098% from the all-time low.</p>
<div class="lb-trans"><p>Planet Labs 是罗素 2000 指数和 IWM ETF 中表现第二好的公司，且不属于生物技术行业。其股价今年最高达到 20.90 美元，比历史最低点上涨了 1,098%。</p>
</div><p>The company, which is in the satellite imagery industry, surged after the management announced strong earnings and guidance. Its most recent numbers showed that its fourth-quarter revenue will be between $76 million and $80 million, higher than the previous guidance of $73.5 million.</p>
<div class="lb-trans"><p>该公司处于卫星图像行业，在管理层宣布强劲的收益和指引后股价大幅上涨。其最新数据显示，第四季度的收入将在 7600 万到 8000 万美元之间，高于之前的指引 7350 万美元。</p>
</div><p>The company also expects that its annual revenue will be between $297 million and $301 million, higher than what analysts were expecting. This growth happened as the company pivoted to government contracts, with its commercial business remaining under pressure.</p>
<div class="lb-trans"><p>该公司还预计年收入将在 2.97 亿到 3.01 亿美元之间，高于分析师的预期。这一增长发生在公司转向政府合同的过程中，而其商业业务仍面临压力。</p>
</div><h2>EcoStar Corporation stock jumps ahead of SpaceX IPO</h2>
<div class="lb-trans"><h2>EcoStar Corporation 股票在 SpaceX IPO 前大幅上涨</h2>
</div><p>The other notable gainer was EchoStar, whose stock jumped by 356% this year. This growth happened as the company continued its partnership with SpaceX. Just recently, the company reached a $2.6 billion deal with SpaceX. Under that deal, the firm will receive $2.6 billion in fees for more spectrum from SpaceX.</p>
<div class="lb-trans"><p>另一家显著的赢家是 EchoStar，其股票今年上涨了 356%。这一增长发生在公司与 SpaceX 继续合作的背景下。最近，该公司与 SpaceX 达成了一项价值 26 亿美元的协议。根据该协议，该公司将获得来自 SpaceX 的 26 亿美元的频谱费用。</p>
</div><p>The company has reached spectrum deals worth over $40 billion with companies like AT&amp;T and SpaceX. Also, analysts expect its deals will accelerate after SpaceX goes public.</p>
<div class="lb-trans"><p>该公司与 AT&amp;T 和 SpaceX 等公司达成的频谱交易总价值超过 400 亿美元。此外，分析师预计在 SpaceX 上市后，其交易将加速。</p>
</div><h2>ThredUp (UP)</h2>
<div class="lb-trans"><h2>ThredUp (UP)</h2>
</div><p>ThredUp, a company offering a platform to second-hand clothes, is another top gainer in the Russell 2000 Index as it jumped by 332% this year. Its growth accelerated as the company continued seeing more demand amid the ongoing inflationary environment.</p>
<div class="lb-trans"><p>ThredUp 是一家提供二手衣物平台的公司，是罗素 2000 指数中的另一家主要赢家，今年上涨了 332%。随着公司在持续的通货膨胀环境中看到更多需求，其增长加速。</p>
</div><p>The stock also jumped as investors saw it as a good turnaround story and the fact that it has established itself as a good asset-light resale infrastructure play. However, its surge has also attracted short-sellers, with its short interest rising to 15%, a sign that some investors anticipate it to retreat soon.</p>
<div class="lb-trans"><p>由于投资者将其视为一个良好的转型故事，并且其已建立起良好的轻资产转售基础设施，其股价也大幅上涨。然而，其股价的飙升也吸引了空头，空头头寸上升至 15%，这表明一些投资者预计其将很快回落。</p>
</div><p>The other top gainers in the Russell 2000 Index were companies like Hecla Mining, Bloom Energy, ViaSat, Better Home &amp; Finance, US Gold, Oklo, and SSR Mining.</p>
<div class="lb-trans"><p>罗素 2000 指数中的其他主要赢家包括 Hecla Mining、Bloom Energy、ViaSat、Better Home &amp; Finance、US Gold、Oklo 和 SSR Mining 等公司。</p>
</div><p>The post Top gainers in the Russell 2000 Index and IWM ETF in 2025 revealed appeared first on Invezz</p>
<div class="lb-trans"><p>本文《2025 年罗素 2000 指数和 IWM ETF 中的主要赢家》首次出现在 Invezz 上。</p>
</div>

2025 年罗素 2000 指数和 IWM ETF 的最大涨幅股揭晓